Tumor lysis syndrome screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Overview
Screening for tumor lysis syndrome is not recommended. However, patients with any hematologic malignancies or acute renal failure should be considered for tumor lysis syndrome workup.
Screening
Screening
- Screening for tumor lysis syndrome is not recommended.[1]
- Patients with malignancies or acute renal failure should be considered for tumor lysis syndrome workup.
References
References
- ↑ Jones, Gail L; Will, Andrew; Jackson, Graham H; Webb, Nicholas J A; Rule, Simon (2015). “Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology”. British Journal of Haematology. 169 (5): 661–671. doi:10.1111/bjh.13403. ISSN 0007-1048.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH